SEC Form 3 · accession 0001209191-18-052587
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Galante
Director
Period of report
Sep 19, 2018
Accepted (ET)
Sep 28, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,350 | D |
Table II — derivative securities
No Table II lines on this filing.